Key result
The CASUS scoring system demonstrated superior outcome prediction for 30-day mortality compared to EuroSCORE II in patients after cardiac surgery.
Why the study?
Do specialized scoring systems (CASUS, EuroSCORE II) improve outcome prediction compared to general scoring systems in patients admitted to a cardiac surgical intensive care unit?
Observational (n=150)
Do specialized scoring systems (CASUS, EuroSCORE II) improve outcome prediction compared to general scoring systems in patients admitted to a cardiac surgical intensive care unit?
Answers are grounded in this paper and cite their sources.
The CASUS scoring system provides superior risk stratification and outcome prediction for 30-day mortality in cardiac surgery patients compared to general ICU scoring systems.
BACKGROUND: Most scoring systems used to predict clinical outcome in critical care were not designed for application in cardiac surgery patients. OBJECTIVES: To compare the predictive ability of the most widely used scoring systems (Acute Physiology and Chronic Health Evaluation [APACHE] II, Simplified Acute Physiology Score [SAPS] II, and Sequential Organ Failure Assessment [SOFA]) and of 2 specialized systems (European System for Cardiac Operative Risk Evaluation [EuroSCORE] II and the cardiac surgery score [CASUS]) for clinical outcome in patients after cardiac surgery. METHODS: Consecutive patients admitted to a cardiac surgical intensive care unit (CSICU) were prospectively studied. Data on the preoperative condition, intraoperative parameters, and postoperative course were collected. EuroSCORE II, CASUS, and scores from 3 general severity-scoring systems (APACHE II, SAPS II, and SOFA) were calculated on the first postoperative day. Clinical outcome was defined as 30-day mortality and in-hospital morbidity. RESULTS: A total of 150 patients were included. Thirty-day mortality was 6%. CASUS was superior in outcome prediction, both in relation to discrimination (area under curve, 0.89) and calibration (Brier score = 0.043, χ(2) = 2.2, P = .89), followed by EuroSCORE II for 30-day mortality (area under curve, 0.87) and SOFA for morbidity (Spearman ρ= 0.37 and 0.35 for the CSICU length of stay and duration of mechanical ventilation, respectively; Wilcoxon W = 367.5, P = .03 for probability of readmission to CSICU). CONCLUSIONS: CASUS can be recommended as the most reliable and beneficial option for benchmarking and risk stratification in cardiac surgery patients.
No takes yet. Share an insight, caveat, or question.
Exarchopoulos et al. (2015) conducted an observational in cardiac surgery (n=150). CASUS (cardiac surgery score) vs. EuroSCORE II, APACHE II, SAPS II, and SOFA was evaluated on 30-day mortality and in-hospital morbidity (AUC 0.89). The CASUS scoring system demonstrated superior outcome prediction for 30-day mortality compared to EuroSCORE II in patients after cardiac surgery.
Synapse has enriched 10 related papers. Consider them for comparative context: